In vitro norepinephrine significantly activates isolated platelets from healthy volunteers and critically ill patients following severe traumatic brain injury

Table 2 Demographic data of 11 consecutively investigated critically ill patients suffering from severe traumatic brain injury

Patient	Age, years	Gender	Initial GCS	Brain lesions	Additional injuries	AIS head	ISS total	Length JB, days	ICU stay, days	eGOS
1	23	Female	15	Mixed	Thorax, skin	5	45	16	41	8
2	54	Male	3	Mixed	-	5	25	5	16	7
3	32	Male	3	Mixed	Thorax, extremities	5	57	24	51	7
4	41	Female	6	Mixed	-	5	25	18	26	8
5	64	Male	6	Mixed	Thorax, abdomen	5	45	7	10	1
6	53	Male	14	Multiple contusions	-	5	25	2	3	1
7	19	Male	12	Mixed	-	5	25	20	27	7
8	49	Male	15	Isolated EDH	Thorax, spine, extremities	5	38	7	21	5
9	51	Male	15	Isolated EDH	Thorax, spine, extremities, pelvis, skin	4	41	4	16	5
10	41	Male	10	Mixed	Thorax, spine, extremities	5	38	10	17	6
11	43	Male	14	Isolated contusion	Face, skin, extremities	5	33	6	12	7
Median, range	43, 23–64	2 females/9 males	11, 3–15	7 mixed lesions	7 with additional injuries	5, 4–5	38, 25–57	7, 2–24	17, 3–51	7, 1–8

Due to individual clinical courses, the jugular venous catheter was removed at different days, resulting in a lower number of patients during the second week (n = 5 versus n = 11, first week). AIS, abbreviated injury score; EDH, epidural hematoma; eGOS, extended Glasgow Outcome Score; GCS, Glasgow Coma Scale score determined at the site of accident; ICU, intensive care unit; ISS, injury severity score; JB, jugular bulb.

ISSN: 1364-8535